A observational, retrospective study for difference in the treatment burden among different types of neovascular age-related macular degeneration (AMD)
Latest Information Update: 02 Sep 2021
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 02 Sep 2021 New trial record